About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
A
HER2 Targeting in Metastatic Colorectal Cancer
By
Andrea Sartore-Bianchi
123 views
September 6, 2022
0 Comments
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
23:58
ASCO GI 2023 Conference Coverage
ASCO GI 2023 Key Studies
Feat.
R. Kim,
R. Mehta
15:51
Total Health
2024 Updates on 1L MSI-H/dMMR mCRC and Using ctDNA MRD Testing in Ea…
Feat.
A. Grothey
13:29
Ibrahim Sahin
Treating KRAS-Mutated mCRC
11:57
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Phase III FIRE-4 Study - Influence of Bas…
Feat.
S. Stintzing
15:56
Van Morris
ASCO Updated Guidelines for the Treatment of Metastatic Colorectal C…
Feat.
C. Eng
18:02
Ibrahim Sahin
Treating HER2-Amplified mCRC
06:26
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "64-Month Follow-Up From CheckMate 142 - 1…
Feat.
H. Lenz
16:39
UChicago Medicine
Treatment of mCRC After Standard Chemotherapy
Feat.
A. Shergill
07:16
Insights from 2024 ASCO® GI Annual Meeting
ASCO® GI 2024 Panel Discussion: "CheckMate-8HW Clinical Implica…
Feat.
Y. Janjigian,
S. Cytryn,
S. Klempner
18:23
Ibrahim Sahin
Treating BRAF-Mutated mCRC
25:57
Northwestern Medicine Oncology and Hematology
ASCO®, ESMO, and NCCN Guidelines on Treatment and Biomarker Testing/…
Feat.
A. Benson
21:24
Fred Hutchinson Cancer Center
Re-Challenge With Systemic Therapy for mCRC
Feat.
R. Hsieh
18:34
Total Health
Management of Colorectal Liver Metastases
Feat.
S. Gholami
06:05
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Updated Results From the GALAXY Study in …
Feat.
E. Oki
25:12
2023 Evolution Conference
IO and Targeted Therapy in mCRC
Feat.
L. Connell
13:17
Heinz-Josef Lenz
Update on Targeted Agents in Colorectal Cancer
08:41
ASCO 2022 Conference Coverage
ASCO 2022 on KEYNOTE-651: Pembrolizumab + mFOLFOX7/FOLFIRI for mCRC:…
Feat.
R. Kim
05:18
Benjamin Weinberg
EGFR Targeted Therapy for mCRC: Differences Between Cetuximab and Pa…
05:30
Julien Taieb
Updated ESMO Guidelines for mCRC
03:11
ecancer
ESMO 2023 Insights: "CodeBreak 300 Phase 3 Study - Sotorasib &a…
Feat.
F. Pietrantonio
